Adolescent and adult differences in major depression symptom profiles

Highlights

• There are etiological and treatment differences between adult and adolescent depression.

• We systematically compared adolescent and adult major depression symptom profiles.

• Appetite/weight change, energy loss and insomnia were common in adolescents.

• Loss of interest/anhedonia and concentration problems were more common in adults.

• Results were similar for Major Depressive Disorder and depressive symptom count.

Abstract

Background

Depression is the leading global cause of disability and often begins in adolescence. The genetic architecture and treatment response profiles for adults and adolescents differ even though identical criteria are used to diagnose depression across different age groups. There is no clear consensus on how these groups differ in their symptom profiles.

Methods

Using data from a two-generation family study, we compared the presentation of DSM-IV depressive symptoms in adolescents and adults with MDD (Major Depressive Disorder). We also compared DSM-IV depressive symptom counts using latent class analysis.

Results

Vegetative symptoms (appetite and weight change, loss of energy and insomnia) were more common in adolescent MDD than adult MDD. Anhedonia/loss of interest and concentration problems were more common in adults with MDD. When using latent class analysis to look at depressive symptoms, a vegetative symptom profile was also seen in adolescent depression only.

Limitations

Adults and adolescents were recruited in different ways. Adolescent cases were more likely to be first-onset while adult cases were recurrences. It was not possible to examine how recurrence affected adolescent depression symptom profiles.

Conclusion

Differences in how depression presents in adolescents and adults may be consistent with different pathophysiological mechanisms. For adolescents, we found that vegetative/physical disturbances were common (loss of energy, changes in weight, appetite and sleep changes). For adults, anhedonia/loss of interest and concentration difficulties were more common.

Introduction

Major depressive disorder (MDD) affects 350 million people worldwide and is the single largest contributor to years lived with disability (Vos et al., 2012). It is the top cause of disability in adolescents and young adults. During adolescence, the incidence of depressive symptoms and MDD increases sharply (Thapar et al., 2012). Adolescence is a risk period for the onset of depression with high recurrence rates and poor functional outcomes (Dunn and Goodyer, 2006).

Identical diagnostic criteria are used to define major depressive disorder in adults and in children/adolescents. The one exception to this is that DSM-IV and 5 (APA 2000, APA 2013) allow irritable rather than depressed mood as a core diagnostic mood symptom for children/adolescents. The use of the same diagnostic criteria in adults, children and adolescents implies that the presentation of the disorder is age-independent. Indeed, there is evidence to support the suggestion that, in terms of risk factors, neural correlates and continuity over time, adolescent-onset MDD can be viewed as an early-onset form of the adult disorder (Maughan et al., 2013, Rutter et al., 2006, Thapar et al., 2012). Nevertheless, there are important aetiological differences between adolescent and adult disorder in terms of treatment response and genetic architecture. The evidence for the effectiveness of antidepressants in treating adolescent depression is sparser than that for adult depression. In particular, selective serotonin reuptake inhibitors (SSRIs) and tricylic antidepressants show smaller effect sizes in treating depression in adolescents compared to adults (Cipriani et al., 2016, Garland et al., 2016, Hazell et al., 1995, Hazell and Mirzaie, 2013, Locher et al., 2017, Thapar et al., 2012). This may be partly due to a higher placebo response for depression in young people (Janiaud et al., 2017). Third generation antidepressants such as SNRIs and mirtazapine have not shown to be significantly better than placebo (Thapar et al., 2012, Locher et al., 2017). Interestingly, the effect size for Cognitive Behavioural Therapy also appears to be lower for adolescent than adult depression (Weisz et al., 2017). Studies also suggest that there is genetic heterogeneity of depression according to age of onset such that a relatively earlier age of onset is more strongly associated with alleles that confer risk for bipolar disorder and schizophrenia compared to later onset depression (Power et al., 2017, Verduijn et al., 2017). Similarly, evidence from twin studies suggests genetic differences between paediatric and adult depression (Lau and Eley, 2010, Rice, 2010, Rice et al., 2002). Collectively, evidence suggests aetiological differences between adolescent and adult depression.

Clinical descriptions of major depressive disorder (MDD) in adolescents also suggest possible differences in the presentation compared to that in adults. In particular that specific vegetative symptoms including appetite and weight disturbance, fatigue and insomnia may be particularly common in clinically depressed children and adolescents (Goodyer and Cooper, 1993, Nardi et al., 2013, Roberts et al., 1995, Ryan et al., 1987). Interestingly, hypersomnia appears less common in young people (Kovacs, 1996). Somatic symptoms which refer to unexplained physical complaints such as musculoskeletal pain or headaches have also been reported as being particularly common in clinically depressed children and adolescents (McCauley et al., 1991, Nardi et al., 2013, Ryan et al., 1987). Probably the largest study of symptom profiles in adolescent depression involved using item response theory to assess the relationship of depressive symptoms to the underlying dimension of depression (Cole et al., 2011). That study identified concentration problems, feelings of worthlessness/guilt and sleep disturbance as present at low levels of depression severity, while psychomotor agitation/retardation, weight and appetite change and suicidal ideation or attempts were present only at high levels of depression severity (Cole et al., 2011). Nonetheless, interpretation of these potential differences in the presentation of MDD between adolescents and adults is obscured due to between-study inconsistencies in how symptoms are assessed and the lack of studies that directly compare adult and adolescent MDD symptoms using similar assessment and recruitment methods. Indeed, it has been highlighted that comparisons have been unsystematic (Kovacs, 1996). There is a need for studies that directly compare the presentation of depressive symptomatology in adolescents to adults in samples using comparable recruitment and assessment methods. A consideration of depressive symptoms would also be informative given that these are functionally impairing, frequently occur in between ‘full-blown’ episodes of clinical depression and predict subsequent major depressive episodes both in adolescents and adults (Angold et al., 1999, Johnson et al., 1992, Judd et al., 1998, Pickles et al., 2001).

In a large study of depression where adults with a history of recurrent MDD and their adolescent offspring were rigorously assessed using similar clinical diagnostic interviews on three occasions, we examined the following research questions:

• Are there differences in the symptomology exhibited by adults and adolescents with a diagnosis of major depressive disorder?

• Are there differences in the profiles of depressive symptoms exhibited by adults and adolescents?